참고문헌
- Armant MA, Fenton MJ (2002). Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol, 3, REVIEWS3011.
- Bickels J, Kollender Y, Merinsky O, Meller I (2002). Coley's toxin: historical perspective. Isr Med Assoc J, 4, 471-2.
- Burdelya LG, Krivokrysenko VI, Tallant TC, et al (2008). An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science, 320, 226-30 https://doi.org/10.1126/science.1154986
- Challacombe JM, Suhrbier A, Parsons PG, et al (2006). Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol, 177, 8123-32. https://doi.org/10.4049/jimmunol.177.11.8123
- Cheng YS, Xu F (2011). Anticancer function of polyinosinicpolycytidylic acid. Cancer Biol Ther, 10, 1219-23.
- Di CE, Forni G, Lollini P, et al (2001). The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood, 97, 339-45. https://doi.org/10.1182/blood.V97.2.339
- Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL (2001). Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol, 167, 1882-5. https://doi.org/10.4049/jimmunol.167.4.1882
- Hartman ZC, Osada T, Glass O, et al (2010). Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity. Cancer Res, 70, 7209-20. https://doi.org/10.1158/0008-5472.CAN-10-0905
- Hicks AM, Riedlinger G, Willingham MC, et al (2006). Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci USA, 103, 7753-8. https://doi.org/10.1073/pnas.0602382103
- Kanzler H, Barrat FJ, Hessel EM, Coffman RL (2007). Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med, 13, 552-9. https://doi.org/10.1038/nm1589
- Kawai T, Akira S (2006). TLR signaling. Cell Death Differ, 13, 816-25. https://doi.org/10.1038/sj.cdd.4401850
- Kawai T, Akira S (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 11, 373-84. https://doi.org/10.1038/ni.1863
- Khoo JJ, Forster S, Mansell A (2011). Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res, 31, 13-25. https://doi.org/10.1089/jir.2010.0095
- Lin YS, Huang LD, Lin CH, et al (2011). In vitro and in vivo anticancer activity of a synthetic glycolipid as TLR4 activator. J Biol Chem, (in press).
- Narayanan P, Lapteva N, Seethammagari M, et al (2011). A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy. J Clin Invest, 121, 1524-34. https://doi.org/10.1172/JCI44327
- Nozawa H, Chiu C, Hanahan D (2006). Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA, 103, 12493-8. https://doi.org/10.1073/pnas.0601807103
- Ostberg JR, Ertel BR, Lanphere JA (2005). An important role for granulocytes in the thermal regulation of colon tumor growth. Immunol Invest, 34, 259-72. https://doi.org/10.1081/IMM-200064477
- Rhee SH, Im E, Pothoulakis C (2008). Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology, 135, 518-28. https://doi.org/10.1053/j.gastro.2008.04.022
- Rhee SH, Im E, Riegler M, et al (2005). Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci USA, 102, 13610-5. https://doi.org/10.1073/pnas.0502174102
- Rhee SH, Kim H, Moyer MP, Pothoulakis C (2006). Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. J Biol Chem, 281, 18560-8. https://doi.org/10.1074/jbc.M513861200
- Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T (2006). TLR3 can directly trigger apoptosis in human cancer cells. J Immunol, 176, 4894-901. https://doi.org/10.4049/jimmunol.176.8.4894
- Thomas JA, Badini M (2011). The role of innate immunity in spontaneous regression of cancer. Indian J Cancer, 48, 246-51. https://doi.org/10.4103/0019-509X.82887
- Tse BW, Russell PJ, Lochner M, Forster I, Power CA (2011). IL- 18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PLoS ONE, 6, e24241. https://doi.org/10.1371/journal.pone.0024241
- Wolska A, Lech-Maranda E, Robak T (2009). Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett, 14, 248-72. https://doi.org/10.2478/s11658-008-0048-z
- Xie Q, Gan L, Wang J, Wilson I, Li L (2007). Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth. Mol Immunol, 44, 3453-61. https://doi.org/10.1016/j.molimm.2007.03.018
- Zhang Y, Luo F, Cai Y, et al (2011). TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. J Immunol, 186, 1963-9. https://doi.org/10.4049/jimmunol.1002320
- Zhang Y, Sun R, Liu B, et al (2009). TLR3 activation inhibits nasopharyngeal carcinoma metastasis via downregulation of chemokine receptor CXCR4. Cancer Biol Ther, 8, 1826-30. https://doi.org/10.4161/cbt.8.19.9437
피인용 문헌
- Toll-like Receptor 5 Agonism Protects Mice from Radiation Pneumonitis and Pulmonary Fibrosis vol.13, pp.9, 2012, https://doi.org/10.7314/APJCP.2012.13.9.4763
- Utilizing bacterial flagellins against infectious diseases and cancers vol.105, pp.2, 2014, https://doi.org/10.1007/s10482-013-0075-2
- Strahlenschutz von Normalgewebszellen vol.190, pp.8, 2014, https://doi.org/10.1007/s00066-014-0637-x
- Role of toll-like receptors in lung cancer vol.34, pp.5, 2014, https://doi.org/10.3109/10799893.2014.903418
- Damage-Associated Molecular Patterns in the Course of Lung Cancer - A Review vol.82, pp.2, 2015, https://doi.org/10.1111/sji.12308
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists vol.8, pp.1663-9812, 2017, https://doi.org/10.3389/fphar.2017.00304
- Repeated injection of KMRC011, a medical countermeasure for radiation, can cause adverse health effects in cynomolgus monkeys pp.0260437X, 2018, https://doi.org/10.1002/jat.3719